GI
STAA icon

GAMCO Investors’s STAAR Surgical STAA Stock Holding History

GAMCO Investors’s Portfolio STAA Stock Details STAA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$374K Buy
20,000
+5,000
+33% +$95.4K ﹤0.01% 844
2025
Q4 		$346K Buy
15,000
+4,000
+36% +$103K ﹤0.01% 892
2025
Q3 		$296K Buy
+11,000
New +$262K ﹤0.01% 911

Other funds holding STAA

BC
Broadwood Capital New York $1.42B AUM 34.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
YC
Yunqi Capital Hong Kong $92.4M AUM 16.3% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AIM
Anatole Investment Management Central, Hong Kong $716M AUM 502.49% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

GAMCO Investors's STAA Position: Q1 2026 in Review

GAMCO Investors increased its STAAR Surgical (STAA) stake by 33% in Q1 2026, buying an estimated $95.4K and bringing the position to 20,000 shares worth $374K. The position accounts for ﹤0.01% of the portfolio, ranked #844.

GAMCO Investors first reported a position in STAA in Q3 2025 and has held it in 3 quarters since. 187 funds tracked by Wall St. Rank hold STAA as of Q1 2026.

  • GAMCO Investors held 20,000 shares of STAAR Surgical worth $374K as of Q1 2026.
  • GAMCO Investors bought 5,000 STAAR Surgical shares in Q1 2026, an estimated $95.4K.
  • STAAR Surgical made up ﹤0.01% of GAMCO Investors's portfolio in Q1 2026, its #844 holding.
  • GAMCO Investors first reported a position in STAAR Surgical in Q3 2025 and has held it in 3 quarters since.
  • 187 funds tracked by Wall St. Rank held STAAR Surgical as of Q1 2026.

Based on GAMCO Investors's 13F filing for Q1 2026, filed 14 May 2026.